Structural Basis of Noscapine Activation for Tubulin Binding

J Med Chem. 2020 Aug 13;63(15):8495-8501. doi: 10.1021/acs.jmedchem.0c00855. Epub 2020 Jul 29.

Abstract

Noscapine is a natural alkaloid that is used as an antitussive medicine. However, it also acts as a weak anticancer agent in certain in vivo models through a mechanism that is largely unknown. Here, we performed structural studies and show that the cytotoxic agent 7A-O-demethoxy-amino-noscapine (7A-aminonoscapine) binds to the colchicine site of tubulin. We suggest that the 7A-methoxy group of noscapine prevents binding to tubulin due to a steric clash of the compound with the T5-loop of α-tubulin. We further propose that the anticancer activity of noscapine arises from a bioactive metabolite that binds to the colchicine site of tubulin to induce mitotic arrest through a microtubule cytoskeleton-based mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Binding Sites / drug effects
  • Colchicine / metabolism
  • Crystallography, X-Ray
  • Drug Design
  • Humans
  • Molecular Docking Simulation
  • Noscapine / analogs & derivatives*
  • Noscapine / chemistry
  • Noscapine / pharmacology
  • Protein Binding / drug effects
  • Tubulin / chemistry
  • Tubulin / metabolism*
  • Tubulin Modulators / chemistry
  • Tubulin Modulators / pharmacology

Substances

  • 9-amino-alpha-noscapine
  • Antineoplastic Agents
  • Tubulin
  • Tubulin Modulators
  • Noscapine
  • Colchicine